Literature DB >> 30283753

Methods of Blood Pressure Assessment Used in Milestone Hypertension Trials.

Yi Chen1, Lei Lei1, Ji-Guang Wang1.   

Abstract

In the present review, we summarized the blood pressure (BP) measurement protocols of contemporary outcome trials in hypertension. In all these trials, clinic BP was used for the diagnosis and therapeutic monitoring of hypertension. In most trials, BP was measured in the sitting position with mercury sphygmomanometers or automated electronic BP monitors by trained observers. BP readings were taken on each occasion at least twice with a 30-to-60-s interval after 5 min of rest. Details regarding the arm side, cuff size, and the timing of BP measurement were infrequently reported. If clinic BP continues being used in future hypertension trials, the measurement should strictly follow current guidelines. The observers must be trained and experienced, and the device should be validated by automated electronic BP monitors. On each occasion, BP readings should be taken 2-3 times. The time interval between successive measurements has to be 30-60 s, and the resting period before the measurement should be at least 5 min in the supine or seated position and 1-3 min standing. BP should usually be measured in the seated position. The higher arm side and an appropriate size cuff should be chosen and noted. BP should be measured at defined trough hours. Automated office BP measurement has recently been used and seems to have less white-coat effect. The out-of-office BP measurement, either ambulatory or home BP monitoring, was only used in a subset of study participants of few hypertension trials. Future trials should consider these novel office or out-of-office BP measurements in guiding the therapy and preventing cardiovascular events.

Entities:  

Keywords:  Assessment; Blood pressure; Clinical trials; Hypertension; Methods

Year:  2018        PMID: 30283753      PMCID: PMC6140594          DOI: 10.1159/000489855

Source DB:  PubMed          Journal:  Pulse (Basel)        ISSN: 2235-8668


  76 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

2.  Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group.

Authors:  L Liu; J G Wang; L Gong; G Liu; J A Staessen
Journal:  J Hypertens       Date:  1998-12       Impact factor: 4.844

3.  Long-term blood pressure control in older Chinese patients with isolated systolic hypertension: a progress report on the Syst-China trial.

Authors:  J G Wang; G Liu; X Wang; S Zhang; M Sun; X Pan; M Jian; L Gong; L Thijs; J Staessen; R Fagard; L Liu
Journal:  J Hum Hypertens       Date:  1996-11       Impact factor: 3.012

Review 4.  Automated blood pressure measurement in atrial fibrillation: a systematic review and meta-analysis.

Authors:  George S Stergiou; Anastasios Kollias; Antonios Destounis; Dimitrios Tzamouranis
Journal:  J Hypertens       Date:  2012-11       Impact factor: 4.844

5.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors:  J A Staessen; R Fagard; L Thijs; H Celis; G G Arabidze; W H Birkenhäger; C J Bulpitt; P W de Leeuw; C T Dollery; A E Fletcher; F Forette; G Leonetti; C Nachev; E T O'Brien; J Rosenfeld; J L Rodicio; J Tuomilehto; A Zanchetti
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

6.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

7.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

8.  Angiotensin II receptor blocker-based vs. non-angiotensin II receptor blocker-based therapy in patients with angiographically documented coronary artery disease and hypertension: the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease (HIJ-CREATE).

Authors:  Hiroshi Kasanuki; Nobuhisa Hagiwara; Saichi Hosoda; Tetsuya Sumiyoshi; Takashi Honda; Kazuo Haze; Michitaka Nagashima; Jun-Ichi Yamaguchi; Hideki Origasa; Mitsuyoshi Urashima; Hiroshi Ogawa
Journal:  Eur Heart J       Date:  2009-04-04       Impact factor: 29.983

Review 9.  Blood pressure lowering for the secondary prevention of stroke: rationale and design for PROGRESS.

Authors: 
Journal:  J Hypertens Suppl       Date:  1996-09

10.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

View more
  8 in total

1.  Determination of optimal on-treatment diastolic blood pressure range using automated measurements in subjects with cardiovascular disease-Analysis of a SPRINT trial subpopulation.

Authors:  Piotr Sobieraj; Jacek Lewandowski; Maciej Siński; Zbigniew Gaciong
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-06-06       Impact factor: 3.738

Review 2.  Monitoring of Treatment for Arterial Hypertension–The Role of Office, Home, and 24 h Ambulatory Blood Pressure Measurement.

Authors:  Thomas Mengden; Burkhard Weisser
Journal:  Dtsch Arztebl Int       Date:  2021-07-12       Impact factor: 5.594

3.  Optimizing observer performance of clinic blood pressure measurement: a position statement from the Lancet Commission on Hypertension Group.

Authors:  Raj Padwal; Norm R C Campbell; Aletta E Schutte; Michael Hecht Olsen; Christian Delles; Anthony Etyang; J Kennedy Cruickshank; George Stergiou; Michael K Rakotz; Gregory Wozniak; Marc G Jaffe; Ivor Benjamin; Gianfranco Parati; James E Sharman
Journal:  J Hypertens       Date:  2019-09       Impact factor: 4.844

4.  Smartphone application-supported validation of three automatic devices for self-measurement of blood pressure according to the European Society of Hypertension International Protocol revision 2010: the Omron HEM-7120, Yuwell YE680A and Cofoe KF-65B.

Authors:  Puhong Zhang; Xi Li; Zhe Fang; Yanling Lu; Jingchen Cui; Xin Du; Rong Hu
Journal:  Blood Press Monit       Date:  2021-12-01       Impact factor: 1.430

5.  Prevalence of hypertension and its associated factors in Hawassa city administration, Southern Ethiopia: Community based cross-sectional study.

Authors:  Tsegab Paulose; Zerish Zethu Nkosi; Misganu Endriyas
Journal:  PLoS One       Date:  2022-03-01       Impact factor: 3.240

6.  Effect of Religious Fasting in Ramadan on Blood Pressure: Results From LORANS (London Ramadan Study) and a Meta-Analysis.

Authors:  Rami Al-Jafar; Maria Zografou Themeli; Sadia Zaman; Sharmin Akbar; Victor Lhoste; Ahlam Khamliche; Paul Elliott; Konstantinos K Tsilidis; Abbas Dehghan
Journal:  J Am Heart Assoc       Date:  2021-10-08       Impact factor: 5.501

7.  Study protocol for family model diabetes self-management education with Marshallese participants in faith-based organizations.

Authors:  Pearl A McElfish; Sheldon Riklon; Rachel S Purvis; Christopher R Long; Holly C Felix; Jonell S Hudson; Derek Alik; Joseph Henske; Dinesh Edem; Gail O'Connor; Janine Boyers; Brett Rowland; James P Selig
Journal:  Contemp Clin Trials Commun       Date:  2022-09-20

8.  Diagnostic Accuracy of Unattended Automated Office Blood Pressure Measurement in Screening for Hypertension in Kenya.

Authors:  Anthony O Etyang; Antipa Sigilai; Emily Odipo; Robinson Oyando; Gerald Ong'ayo; Lawrence Muthami; Kenneth Munge; Fredrick Kirui; Jane Mbui; Zipporah Bukania; Judy Mwai; Andrew Obala; Edwine Barasa
Journal:  Hypertension       Date:  2019-10-07       Impact factor: 10.190

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.